The Power and Potential of Genetic Medicine
Genetic medicine is poised to unlock more value for patients and investors. RBC’s biotechnology analyst Luca...
The Competitive Landscape of Gene Therapy and Immuno-oncology
The road is paved for gene therapy and immuno-oncology treatment innovation in 2023 as emerging clinical...
The Hidden Revolution Set to Turn US Healthcare on its Head
In this episode of Pathfinders, RBC’s Healthcare Technology Analyst Sean Dodge discusses the value-based...
The Big Picture for Biotech
In this latest episode, our head of biotech research Brian Abrahams shares a big picture analysis of the...
Why Biopharma Investment Requires a Different Mindset
In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital...
The Optimism Behind the Biopharma Market
Dr. Chen Yu, Founder and Managing Partner at TCG X, discusses why he is optimistic about biotech, and what’s...
Biotech Investors: How to Find Value in a Bear Market
How are top investors navigating the longest biotech bear market in almost 20 years?
Biotech SPACs: A New Route to Going Public
As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies...
Pathfinders in Biopharma Podcast
Our podcast series explores the fast-moving world of biopharma and what the road ahead looks like for companies and investors in the sector.
More Healthcare insights
From biotech breakthroughs to digital transformation, our global healthcare specialists dive deep into the latest trends, innovations, and emerging opportunities.
Stay Informed
Get the latest insights from RBC Capital Markets delivered to your inbox.